Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis
NCT: NCT07706998 · NOT_YET_RECRUITING
Brief Summary
Aim: To evaluate the application effect of the teaching platform iLN in the teaching of lupus nephritis, aiming to provide practical experience and evidence-based support for the implementation of generative AI technology in professional medical education. Method: Based on the DeepSeek large language model, the investigators developed "iLN" - an interactive teaching platform for lupus nephritis. This platform integrates the latest authoritative textbooks, clinical guidelines, pathological atlases, and real clinical cases, and includes seven core modules, such as "case interaction", "knowledge teaching", and "AI question answering". The investigators conducted a randomized controlled trial (RCT) on 50 fourth-year undergraduate students from Nanjing University School of Medicine to evaluate the effectiveness of the iLN platform compared to traditional teaching methods. The teaching effect was evaluated through objective test scores and questionnaires about student satisfaction and platform usability.
Frequently Asked Questions
What is Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis?
Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis is a clinical trial registered under NCT07706998. Current status: NOT_YET_RECRUITING.
What is the status of NCT07706998?
The current status of NCT07706998 (Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis) is: NOT_YET_RECRUITING.
When did Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis start?
Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis started on 2026-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.